JPRN-UMIN000010431已完成1 期
Phase I study of transarterial chemoembolization using Cisplatin powder and miriplatin in patients with hepatocellular carcinoma - Phase I study of doubleplatinum TACE for HCC
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)History of hypersensitivity reaction 2)Other severe complications, such as uncontrollable diabetes or heart failure, renal insufficiency, liver failure 3)Active another cancer 4)Pregnant or possibility pregnancy or nursing woman 5) Physician judged improper to entry this trial
研究者
相似试验
已完成
不适用
A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)nresectable hypervascular hepatocellular carcinomaJPRN-C000000049Japan Interventional Radiology in Oncology Study Group (JIVROSG)60
进行中（未招募）
不适用
Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) - TACE and sorafenib for HCChistologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCCMedDRA version: 9.1Level: LLTClassification code 10019828Term: Hepatocellular carcinoma non-resectableEUCTR2007-000730-40-DEHeinrich-Heine-Universität Düsseldorf
已完成
2 期
Phase II trial of Transarterial Chemoembolization using Drug-eluting bead for advanced HCC refractory to Lipiodol-TACEadvanced hepatocellular carcinomaJPRN-UMIN000015463Clinical Research Group of the Japanese Society for Transcatheter Hepatic Arterial Embolization24
已完成
1 期
Phase I/II study of transcatheter arterial chemo-embolization with DDP-H and degradable starch microspheres for hepatic metastases of colorectal cancerColorectal CancerJPRN-UMIN000001168Radiology, Nara Medical University Hospital27
已完成
2 期
PhaseII study of trancatheter arterial chemoembolizaion with miriplatin for hepatocellular carcinoma -Compared with retrospective historical cohort study with epirubicin hydrochlorideHepatocellular carcinomaJPRN-UMIN000005229ara Medical University, Department of Radiology33